Protein C Depletion Early After Trauma Increases the Risk of Ventilator-Associated Pneumonia

被引:35
作者
Cohen, Mitchell J. [1 ]
Bir, Natasha [1 ]
Rahn, Pamela
Dotson, Rachel [3 ]
Brohi, Karim [4 ]
Chesebro, Brian B. [2 ]
Mackersie, Robert [1 ]
Carles, Michel [2 ]
Wiener-Kronish, Jeanine [5 ]
Pittet, Jean-Francois [1 ,2 ]
机构
[1] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Anesthesia, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
[4] Royal London Hosp, London E1 1BB, England
[5] Harvard Univ, Sch Med, Dept Anaesthesia, Massachusetts Gen Hosp, Boston, MA 02115 USA
来源
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE | 2009年 / 67卷 / 06期
关键词
Ventilator-associated pneumonia; Trauma; Coagulopathy; Protein C; SEVERE SEPSIS; CONSENSUS CONFERENCE; ACUTE COAGULOPATHY; INJURY SEVERITY; PATHWAY; HYPOPERFUSION; COMPLICATIONS; PREDICTORS; ACTIVATION; MORTALITY;
D O I
10.1097/TA.0b013e3181c1c1bc
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Introduction: Mechanically ventilated trauma patients have a high risk for the development of ventilator-associated pneumonia (VAP). We have recently reported that reduced plasma protein C (PC) levels early after trauma/shock are associated with coagulopathy and mortality. Furthermore, trauma patients with tissue injury and shock are at higher risk for the development of VAP. Objective: We hypothesized that low PC levels early after trauma are associated with an increased susceptibility to VAP in trauma patients. Methods: Fifty-nine acutely injured, intubated trauma patients were admitted to the critical care unit. Serial blood samples were drawn and coagulation factors were measured. VAP was diagnosed by presence of bacteria bronchial alveolar lavage specimen, bilateral infiltrates on chest roentgenogram, and fever or elevated white blood cell count. Results: There were no differences in demographic or injury characteristics between patients who developed VAP and those who did not. As expected, patients who developed VAP had more ventilator days, hospital days.. e. intensive care unit days, and greater mortality (all p < 0.05). Patients in both groups had lower mean PC levels at 6 hours compared with baseline. Noninfected patients' PC subsequently returned to nearbaseline levels, whereas those patients who eventually acquired VAP had significantly lower PC levels at both 12 and 24 hours (12 hours: 79 vs. 96%, p = 0.05; 24 hours: 75 vs. 97% p = 0.02). Soluble endothelial PC receptor (sEPCR) levels were also lower at 24 hours (82 vs. 99% in the noninfected group, p = 0.04). Discussion: The activation of PC pathway early after trauma may protect the vascular endothelium by both its anticoagulant and cytoprotective effects. However, trauma patients who later developed VAP have significantly lower plasma levels of PC within 24 hours after injury, suggesting a possible consumption of this vitamin K-dependent protein and an inhibition of its activation by inflammatory mediators. EPCR is involved in the activation of PC and is also a mediator of its cytoprotective effects. Conclusion: Critically ill trauma patients have an early activation of the PC pathway, associated with a rapid decrease in the plasma levels of this protein and increase in EPCR. Plasma levels of PC return to normal levels within 24 hours in most patients. However, patients who go on to acquire VAP have persistently low plasma levels of PC in the immediate period after trauma. Whether PC could play a mechanistic role in the host response against nosocomial lung infection warrants further study.
引用
收藏
页码:1176 / 1181
页数:6
相关论文
共 33 条
[1]  
[Anonymous], 2003, MMWR, V52, P1
[2]  
Asaka S, 1996, LIVER, V16, P183
[3]   INJURY SEVERITY SCORE - METHOD FOR DESCRIBING PATIENTS WITH MULTIPLE INJURIES AND EVALUATING EMERGENCY CARE [J].
BAKER, SP ;
ONEILL, B ;
HADDON, W ;
LONG, WB .
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 1974, 14 (03) :187-196
[4]   Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group [J].
Bellomo, R ;
Ronco, C ;
Kellum, JA ;
Mehta, RL ;
Palevsky, P .
CRITICAL CARE, 2004, 8 (04) :R204-R212
[5]   Extended evaluation of recombinant human activated protein C United States trial (ENHANCE US) - A single-arm, phase 313, multicenter study of drotrecogin alfa (activated) in severe sepsis [J].
Bernard, GR ;
Margolis, BD ;
Shanies, HM ;
Ely, EW ;
Wheeler, AP ;
Levy, H ;
Wong, K ;
Wright, TJ ;
Ahmed, M ;
Albertson, T ;
Anas, N ;
Astiz, M ;
Bacon, A ;
Bandi, V ;
Booth, F ;
Bray, W ;
Brilli, R ;
Carlson, R ;
Cheatham, M ;
Conrad, S ;
Cooney, R ;
Cox, M ;
Dolich, M ;
Dries, D ;
Fang, R ;
Forse, R ;
Fricker, R ;
Givens, C ;
Gomez, C ;
Gottlieb, J ;
Graham, D ;
Cropper, I ;
Cross, T ;
Harrison, N ;
Kearl, R ;
Kearney, P ;
Kinasewitz, G ;
Kruse, J ;
Lamberti, J ;
Levy, M ;
Light, R ;
Lin, L ;
Lisco, S ;
Lo, T ;
Linda, L ;
Lodato, R ;
Malave, L ;
Martinez, A ;
Mastuschak, G ;
McDermott, L .
CHEST, 2004, 125 (06) :2206-2216
[6]   THE AMERICAN-EUROPEAN CONSENSUS CONFERENCE ON ARDS - DEFINITIONS, MECHANISMS, RELEVANT OUTCOMES, AND CLINICAL-TRIAL COORDINATION [J].
BERNARD, GR ;
ARTIGAS, A ;
BRIGHAM, KL ;
CARLET, J ;
FALKE, K ;
HUDSON, L ;
LAMY, M ;
LEGALL, JR ;
MORRIS, A ;
SPRAGG, R ;
COCHIN, B ;
LANKEN, PN ;
LEEPER, KV ;
MARINI, J ;
MURRAY, JF ;
OPPENHEIMER, L ;
PESENTI, A ;
REID, L ;
RINALDO, J ;
VILLAR, J ;
VANASBECK, BS ;
DHAINAUT, JF ;
MANCEBO, J ;
MATTHAY, M ;
MEYRICK, B ;
PAYEN, D ;
PERRET, C ;
FOWLER, AA ;
SCHALLER, MD ;
HUDSON, LD ;
HYERS, T ;
KNAUS, W ;
MATTHAY, R ;
PINSKY, M ;
BONE, RC ;
BOSKEN, C ;
JOHANSON, WG ;
LEWANDOWSKI, K ;
REPINE, J ;
RODRIGUEZROISIN, R ;
ROUSSOS, C ;
ANTONELLI, MA ;
BELOUCIF, S ;
BIHARI, D ;
BURCHARDI, H ;
LEMAIRE, F ;
MONTRAVERS, P ;
PETTY, TL ;
ROBOTHAM, J ;
ZAPOL, W .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 149 (03) :818-824
[7]   Efficacy and safety of recombinant human activated protein C for severe sepsis. [J].
Bernard, GR ;
Vincent, JL ;
Laterre, P ;
LaRosa, SP ;
Dhainaut, JF ;
Lopez-Rodriguez, A ;
Steingrub, JS ;
Garber, GE ;
Helterbrand, JD ;
Ely, EW ;
Fisher, CJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) :699-709
[8]   Acute coagulopathy of trauma: Hypoperfusion induces systemic anticoagulation and hyperfibrinolysis [J].
Brohi, Karim ;
Cohen, Mitchell J. ;
Ganter, Michael T. ;
Schultz, Marcus J. ;
Levi, Marcel ;
Mackersie, Robert C. ;
Pittet, Jean-Francois .
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 2008, 64 (05) :1211-1217
[9]   Acute coagulopathy of trauma: mechanism, identification and effect [J].
Brohi, Karim ;
Cohen, Mitchell J. ;
Davenport, Ross A. .
CURRENT OPINION IN CRITICAL CARE, 2007, 13 (06) :680-685
[10]   Acute traumatic coagulopathy: Initiated by hypoperfusion - Modulated through the protein C pathway? [J].
Brohi, Karim ;
Cohen, Mitchell J. ;
Ganter, Michael T. ;
Matthay, Michael A. ;
Mackersie, Robert C. ;
Pittet, Jean-Francois .
ANNALS OF SURGERY, 2007, 245 (05) :812-818